Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 08 May 2019 for Amneal Pharmaceuticals, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Robert l. Burr: trading record in brief
Filings by Robert l. Burr span 2 companies, the busiest being Impax Laboratories, LLC and Amneal Pharmaceuticals, Inc. The record holds 9 filings, for trades running from 17 May 2016 to 8 May 2019.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 8 May 2019, the filings show an option exercise in Amneal Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert l. Burr
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
6,107 sharesClass A Common StockSEC:0001723128-19-000069:0
30,000 shares@ US$6.55100.0% of flowClass A Common StockSEC:0001723128-19-000013:0
60,475 sharesClass A Common StockSEC:0000899243-18-011945:0
6,057 sharesClass A Common StockSEC:0000899243-18-011945:1
55,067 sharesCommon StockSEC:0001003642-18-000083:0
6,057 sharesCommon StockSEC:0001003642-18-000083:1
5,408 sharesRestricted Common StockSEC:0001003642-18-000083:2
4,375 shares0Common StockSEC:0001003642-17-000049:0
4,375 shares0Common StockSEC:0001437749-16-032323:0
9 of 9 declarations
